Open Access
Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins
Sergei A Fedotov
1, 2
,
Maria S. Rubel
3
,
Natalia M Zalutskaya
4
,
Anastasia E Zobnina
1, 5
,
Oksana A Malikova
1, 5
,
Nikolay G Neznanov
4
,
Yury O Chernoff
1, 6
,
Aleksandr A. Rubel
1, 5, 7
4
Publication type: Journal Article
Publication date: 2021-01-01
scimago Q3
wos Q4
SJR: 0.555
CiteScore: 3.6
Impact factor: 1.6
ISSN: 19336896, 1933690X
PubMed ID:
33910450
Biochemistry
Cell Biology
Infectious Diseases
Cellular and Molecular Neuroscience
Abstract
ABSTRACT Alzheimer’s disease (AD) is the most common form of dementia that usually occurs among older people. AD results from neuronal degeneration that leads to the cognitive impairment and death. AD is incurable, typically develops over the course of many years and is accompanied by a loss of functional autonomy, making a patient completely dependent on family members and/or healthcare workers. Critical features of AD are pathological polymerization of Aβ peptide and microtubule-associated protein tau, accompanied by alterations of their conformations and resulting in accumulation of cross-β fibrils (amyloids) in human brains. AD apparently progresses asymptomatically for years or even decades before the appearance of symptoms. Therefore, development of the early AD diagnosis at a pre-symptomatic stage is essential for potential therapies. This review is focused on current and potential molecular tools (including non-invasive methods) that are based on detection of amyloidogenic proteins and can be applicable to early diagnosis of AD. Abbreviations: Aβ – amyloid-β peptide; AβO – amyloid-β oligomers; AD – Alzheimer’s disease; ADRDA – Alzheimer’s Disease and Related Disorders Association; APH1 - anterior pharynx defective 1; APP – amyloid precursor protein; BACE1 – β-site APP-cleaving enzyme 1; BBB – brain blood barrier; CJD - Creutzfeldt-Jakob disease; CRM – certified reference material; CSF – cerebrospinal fluid; ELISA – enzyme-linked immunosorbent assay; FGD – 18F-fluorodesoxyglucose (2-deoxy-2-[18F]fluoro-D-glucose); IP-MS – immunoprecipitation-mass spectrometry assay; MCI – mild cognitive impairment; MDS – multimer detection system; MRI – magnetic resonance imaging; NIA-AA – National Institute on Ageing and Alzheimer’s Association; NINCDS – National Institute of Neurological and Communicative Disorders and Stroke; PEN2 – presenilin enhancer 2; PET – positron emission tomography; PiB – Pittsburgh Compound B; PiB-SUVR - PIB standardized uptake value ratio; PMCA – Protein Misfolding Cycling Amplification; PrP – Prion Protein; P-tau – hyperphosphorylated tau protein; RMP – reference measurement procedure; RT-QuIC - real-time quaking-induced conversion; SiMoA – single-molecule array; ThT – thioflavin T; TSEs – Transmissible Spongiform Encephslopathies; T-tau – total tau protein
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
1
2
3
|
|
|
Frontiers in Aging Neuroscience
3 publications, 15%
|
|
|
International Journal of Molecular Sciences
2 publications, 10%
|
|
|
Clinical and Translational Oncology
1 publication, 5%
|
|
|
Aging clinical and experimental research
1 publication, 5%
|
|
|
ACS applied materials & interfaces
1 publication, 5%
|
|
|
Brain Research Bulletin
1 publication, 5%
|
|
|
Cells
1 publication, 5%
|
|
|
BMC Neurology
1 publication, 5%
|
|
|
Life
1 publication, 5%
|
|
|
European Journal of Medicinal Chemistry
1 publication, 5%
|
|
|
ACS Chemical Neuroscience
1 publication, 5%
|
|
|
Physics of Particles and Nuclei
1 publication, 5%
|
|
|
Microchemical Journal
1 publication, 5%
|
|
|
Lecture Notes in Computer Science
1 publication, 5%
|
|
|
ChemBioChem
1 publication, 5%
|
|
|
Developmental Neurobiology
1 publication, 5%
|
|
|
Journal of Neurochemistry
1 publication, 5%
|
|
|
1
2
3
|
Publishers
|
1
2
3
4
|
|
|
MDPI
4 publications, 20%
|
|
|
Springer Nature
4 publications, 20%
|
|
|
Frontiers Media S.A.
3 publications, 15%
|
|
|
Elsevier
3 publications, 15%
|
|
|
Wiley
3 publications, 15%
|
|
|
American Chemical Society (ACS)
2 publications, 10%
|
|
|
Pleiades Publishing
1 publication, 5%
|
|
|
1
2
3
4
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
20
Total citations:
20
Citations from 2025:
2
(10%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Kulichikhin K. Y. et al. Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins // Prion. 2021. Vol. 15. No. 1. pp. 56-69.
GOST all authors (up to 50)
Copy
Kulichikhin K. Y., Fedotov S. A., Rubel M. S., Zalutskaya N. M., Zobnina A. E., Malikova O. A., Neznanov N. G., Chernoff Y. O., Rubel A. A. Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins // Prion. 2021. Vol. 15. No. 1. pp. 56-69.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1080/19336896.2021.1917289
UR - https://doi.org/10.1080/19336896.2021.1917289
TI - Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins
T2 - Prion
AU - Kulichikhin, Konstantin Y
AU - Fedotov, Sergei A
AU - Rubel, Maria S.
AU - Zalutskaya, Natalia M
AU - Zobnina, Anastasia E
AU - Malikova, Oksana A
AU - Neznanov, Nikolay G
AU - Chernoff, Yury O
AU - Rubel, Aleksandr A.
PY - 2021
DA - 2021/01/01
PB - Taylor & Francis
SP - 56-69
IS - 1
VL - 15
PMID - 33910450
SN - 1933-6896
SN - 1933-690X
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2021_Kulichikhin,
author = {Konstantin Y Kulichikhin and Sergei A Fedotov and Maria S. Rubel and Natalia M Zalutskaya and Anastasia E Zobnina and Oksana A Malikova and Nikolay G Neznanov and Yury O Chernoff and Aleksandr A. Rubel},
title = {Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins},
journal = {Prion},
year = {2021},
volume = {15},
publisher = {Taylor & Francis},
month = {jan},
url = {https://doi.org/10.1080/19336896.2021.1917289},
number = {1},
pages = {56--69},
doi = {10.1080/19336896.2021.1917289}
}
Cite this
MLA
Copy
Kulichikhin, Konstantin Y., et al. “Development of molecular tools for diagnosis of Alzheimer’s disease that are based on detection of amyloidogenic proteins.” Prion, vol. 15, no. 1, Jan. 2021, pp. 56-69. https://doi.org/10.1080/19336896.2021.1917289.